Nexus 2020 Virtual will provide focused, essential learning opportunities starting with a preconference “Critical Conversations” on Monday, October 19 followed by a week of programming through Friday, October 23.

Browse the following list of Carelon Research presentations, including an opportunity to chat live with Carelon Research Principal Scientist, Dr. Michael Grabner, Wednesday, October 21 from 1:00 – 2:30 PM EDT.

Carelon Research presentations

Carelon Research authors are indicated in bold.





Virtual presentation

C40 | Healthcare resource utilization among first line tyrosine kinase inhibitor therapy for patients with metastatic renal cell carcinoma

Perez J1, Singhal M2, Lawless G3, Shambhu S5, McKay RR4, Wallace JF1, Barron J5, Grabner M5

1Exelixis, Alameda, CA; 2Carelon Research, Watertown, MA; 3Dos Vientos Consulting, Thousand Oaks, CA; 4Moores Cancer Center, University of California San Diego, San Diego, CA; 5Carelon Research, Wilmington, DE

Virtual presentation

C46 | Healthcare resource utilization and total direct costs of care over time among persistent ibrutinib patients with chronic lymphocytic leukemia

Challagulla S1, Singhal M2, Gangan N4, Ibrahim K3, Volodarsky R1, Tan H4, Giafis N1, Iyengar R1

1Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA; 2Carelon Research, Watertown, MA; 3The University of Texas at Austin, Austin, TX; 4Carelon Research, Wilmington, DE

Virtual presentation

Live Chat
October 21
1:00 – 2:30 PM EDT

D14 | Economic burden of acute steroid-refractory graft-versus host disease in commercially insured pediatric patients

Grabner M1, Strati E2, Sandman K3, Forsythe A3

1Carelon Research, Wilmington, DE; 2Mesoblast Inc., New York, NY; 3Purple Squirrel Economics, New York, NY

Ready to learn more? Let's connect.